Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17642438 | 1.00 | NOS2 (0.31) | NOS2 | |
| SCHEMBL18419229 | 1.00 | NOS2 (0.31) | NOS2 | |
| SCHEMBL36547 | 1.00 | NOS2 (0.31) | NOS2 | |
| SCHEMBL18419228 | 1.00 | NOS2 (0.31) | NOS2 | |
| SCHEMBL15809089 | 1.00 | NOS2 (0.31) | NOS2 | |
| SCHEMBL15809090 | 0.92 | — | — | |
| SCHEMBL1188985 | 0.91 | — | — | |
| SCHEMBL30894549 | 0.85 | — | — | |
| SCHEMBL8062477 | 0.85 | SMN1; SMN2 (0.36) | — | |
| SCHEMBL798034 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220177693-A1 | METHOD OF EPOXIDATION | UNIVERSITY OF DURHAM (GB) | 2022-06-09 | — | — | US | disclosed |
| US-10723817-B2 | Vinyl modifier composition and processes for utilizing such composition | BRIDGESTONE CORPORATION (JP) | 2020-07-28 | — | — | US | disclosed |
| US-10000460-B2 | Chelate-controlled diastereoselective hydrogenation with heterogeneous catalyst | THOMAS SWAN & CO. LTD (GB) | 2018-06-19 | — | — | US | disclosed |
| US-10000460-B2 | Chelate-controlled diastereoselective hydrogenation with heterogeneous catalyst | THOMAS SWAN & CO. LTD (GB) | 2018-06-19 | — | — | US | disclosed |
| US-20180134815-A1 | Vinyl Modifier Composition And Processes For Utilizing Such Composition | BRIDGESTONE CORPORATION (JP) | 2018-05-17 | — | — | US | disclosed |
| EP-3134203-B1 | CHELATE-CONTROLLED DIASTEREOSELECTIVE HYDROGENATION WITH HETEROGENEOUS CATALYST | SWAN THOMAS & CO LTD (GB) | 2018-04-04 | — | — | EP | disclosed |
| US-9868795-B2 | Vinyl modifier composition and processes for utilizing such composition | BRIDGESTONE CORPORATION (JP) | 2018-01-16 | — | — | US | disclosed |
| US-9751848-B2 | Chelate-controlled diastereoselective hydrogenation with heterogeneous catalyst | THOMAS SWAN & CO. LTD (GB) | 2017-09-05 | — | — | US | disclosed |
| US-9751848-B2 | Chelate-controlled diastereoselective hydrogenation with heterogeneous catalyst | THOMAS SWAN & CO. LTD (GB) | 2017-09-05 | — | — | US | disclosed |
| US-20170197929-A1 | CHELATE-CONTROLLED DIASTEREOSELECTIVE HYDROGENATION WITH HETEROGENEOUS CATALYST | THOMAS SWAN & CO. LTD (GB) | 2017-07-13 | — | — | US | disclosed |
| US-20170029394-A1 | CHELATE-CONTROLLED DIASTEREOSELECTIVE HYDROGENATION WITH HETEROGENEOUS CATALYST | THOMAS SWAN & CO. LTD (GB) | 2017-02-02 | — | — | US | disclosed |
| US-20160237181-A1 | Vinyl Modifier Composition And Processes For Utilizing Such Composition | BRIDGESTONE CORPORATION (JP) | 2016-08-18 | — | — | US | disclosed |
| US-9309330-B2 | Vinyl modifier composition and processes for utilizing such composition | BRIDGESTONE CORPORATION (JP) | 2016-04-12 | — | — | US | disclosed |
| WO-2016046575-A1 | CHELATE-CONTROLLED DIASTEREOSELECTIVE HYDROGENATION WITH HETEROGENEOUS CATALYST | THOMAS SWAN & CO. LTD (GB) | 2016-03-31 | — | — | WO | disclosed |
| US-20150284483-A1 | Vinyl Modifier Composition And Processes For Utilizing Such Composition | BRIDGESTONE CORPORATION (JP) | 2015-10-08 | — | — | US | disclosed |
| US-9062017-B2 | Vinyl modifier composition and processes for utilizing such composition | BRIDGESTONE CORPORATION (JP) | 2015-06-23 | — | — | US | disclosed |
| EP-2516410-B1 | IMPROVED VINYL MODIFIER COMPOSITION AND PROCESSES FOR UTILIZING SUCH COMPOSITION | BRIDGESTONE CORP (JP) | 2014-04-23 | — | — | EP | disclosed |
| EP-2516410-A1 | IMPROVED VINYL MODIFIER COMPOSITION AND PROCESSES FOR UTILIZING SUCH COMPOSITION | Bridgestone Corporation (JP) | 2012-10-31 | — | — | EP | disclosed |
| US-20120259082-A1 | VINYL MODIFIER COMPOSITION AND PROCESSES FOR UTILIZING SUCH COMPOSITION | BRIDGESTONE CORPORATION (JP) | 2012-10-11 | — | — | US | disclosed |
| WO-2011087841-A1 | IMPROVED VINYL MODIFIER COMPOSITION AND PROCESSES FOR UTILIZING SUCH COMPOSITION | BRIDGESTONE CORPORATION (JP) | 2011-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10000460-B2 | Chelate-controlled diastereoselective hydrogenation with heterogeneous catalyst | CAT, CTCF, CEL | NOS2 3867/4885 |
| US-20170197929-A1 | CHELATE-CONTROLLED DIASTEREOSELECTIVE HYDROGENATION WITH HETEROGENEOUS CATALYST | CAT, CEL, CTCF | NOS2 3194/4885 |
| US-20120259082-A1 | VINYL MODIFIER COMPOSITION AND PROCESSES FOR UTILIZING SUCH COMPOSITION | VCL, MVD, VAV1 | NOS2 2429/4885 |
| US-20170029394-A1 | CHELATE-CONTROLLED DIASTEREOSELECTIVE HYDROGENATION WITH HETEROGENEOUS CATALYST | CAT, CEL, CTCF | NOS2 3194/4885 |
| US-20160237181-A1 | Vinyl Modifier Composition And Processes For Utilizing Such Composition | VCL, MVD, VAV1 | NOS2 2960/4885 |
| US-10723817-B2 | Vinyl modifier composition and processes for utilizing such composition | VCL, MVD, VAV1 | NOS2 2960/4885 |
| US-20180134815-A1 | Vinyl Modifier Composition And Processes For Utilizing Such Composition | VCL, MVD, VAV1 | NOS2 2960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.